# Tris Pharma Inc. – FDA Inspection, Mar 8, 2024

Source: https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/99d56376-6034-4b6d-bb10-9c0588ba3b2d
Source feed: FDA_Inspections

> FDA inspection 1232735 of Tris Pharma Inc., March 08, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1232735
- Company Name: Tris Pharma Inc.
- Inspection Date: 2024-03-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1289086 - 2025-11-21](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/b0a66ca1-e50e-48d8-8bb1-9e1b4802753b)
- [FDA Inspection 1143403 - 2021-06-08](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/0d3df2aa-17b0-4cd8-b8b1-3c73c074e44d)
- [FDA Inspection 1076980 - 2019-01-23](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/2d9231c8-f86c-4a28-96c0-54d7c9c16c2c)
- [FDA Inspection 1048300 - 2018-04-16](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/868cb111-c9ed-4744-857d-5d267514ece7)
- [FDA Inspection 1010216 - 2017-03-20](https://www.keypedia.com/records/fda_inspections/tris-pharma-inc/bbcf743c-d4e0-4c1b-9f1e-81f82bd0e447)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/asia-d-clark/261919ba-8899-4703-8b58-57821f0bf0a5)
- [Company Rep](https://www.keypedia.com/people/emily-a-baldwin/92d70174-7029-44f4-af30-e3230d4e9507)
- [Company Rep](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)

Company: https://www.keypedia.com/companies/tris-pharma-inc/65a6590a-3777-454b-bf0d-a9d37e3bf58e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c